Nationwide and population-based prescription patterns in bipolar disorder

Bipolar Disorders

Volumn 18, Issue 2, 2016, Pages 174-182

  Kessing, Lars Vedel ^a,b   Vradi, Eleni ^c   Andersen, Per Kragh ^c  

^a Psychiatric Center Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Bipolar disorder; Drug treatment; Mania; Pharmacological treatment; Prescription patterns

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; LAMOTRIGINE; LITHIUM; QUETIAPINE; NEUROLEPTIC AGENT;

ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DATA ANALYSIS; DENMARK; DISEASE ASSOCIATION; HUMAN; LONGITUDINAL STUDY; MEDICAL SERVICE; MENTAL HEALTH CARE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; ADULT; CLINICAL PRACTICE; FEMALE; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; REGISTER; STATISTICS AND NUMERICAL DATA; TRENDS;

ADULT; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DENMARK; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LITHIUM; MALE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; PRACTICE PATTERNS, PHYSICIANS'; REGISTRIES;

EID: 84975733496     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12371     Document Type: Article

References (31)

1. Verdoux H, Begaud B. Pharmaco-epidemiology: what do (and don't) we know about utilisation and impact of psychotropic medications in real-life conditions? Br J Psychiatry 2004; 185: 93-94.
2. Bauer MS. A review of quantitative studies of adherence to mental health clinical practice guidelines. Harv Rev Psychiatry 2002; 10: 138-153.
3. Blanco C, Laje G, Olfson M, Marcus SC, Pincus HA. Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am J Psychiatry 2002; 159: 1005-1010.
4. Frangou S, Raymont V, Bettany D. The Maudsley bipolar disorder project. A survey of psychotropic prescribing patterns in bipolar I disorder. Bipolar Disord 2002; 4: 378-385.
5. Dennehy EB, Suppes T, John RA, Lynn CM, Witte B, Webster J. Development of a computerized assessment of clinician adherence to a treatment guideline for patients with bipolar disorder. J Psychiatr Res 2004; 38: 285-294.
6. Baldessarini RJ, Leahy L, Arcona S, Gause D, Zhang W, Hennen J. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv 2007; 58: 85-91.
7. Dennehy EB, Suppes T, Rush AJ et al. Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project. Psychol Med 2005; 35: 1695-1706.
8. Hayes J, Prah P, Nazareth I et al. Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. PLoS ONE 2011; 6: e28725.
9. Depp C, Ojeda VD, Mastin W, Unutzer J, Gilmer TP. Trends in use of antipsychotics and mood stabilizers among Medicaid beneficiaries with bipolar disorder, 2001-2004. Psychiatr Serv 2008; 59: 1169-1174.
10. Hooshmand F, Miller S, Dore J et al. Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011. J Affect Disord 2014; 155: 283-287.
11. Munk-Jorgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan Med Bull 1997; 44: 82-84.
12. Danish National Board of Health L. Medicinal Product Statistics. Available from: http://esundhed.dk/dokumentation/Registre/Sider/Register.aspx?rp:A_Register=14&rp:Visning=0&, 2016 [accessed February 2016].
13. Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull 1999; 46: 354-357.
14. Andersen TF, Madsen M, Jorgensen J, Mellemkjaer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-268.
15. World Health Organisation. Klassifikation af sygdomme. Systematisk del. International Statistical Classification of Diseases and Health Related Problems, Tenth revision (Danish Edition). Copenhagen: Munksgaard, 1993.
16. WHO Collaborating Centre for Drug Statistics Methodology. ATC Index with DDDs. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2003.
17. Severus E, Taylor MJ, Sauer C et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord 2014; 2: 15.
18. Goodwin GM. Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009; 23: 346-388.
19. Grunze H, Vieta E, Goodwin GM et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry 2013; 14: 154-219.
20. Yatham LN, Kennedy SH, Parikh SV et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2013; 15: 1-44.
21. NICE. Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care. NICE Clinical Guideline 185, 2015.
22. Nolen WA. More robust evidence for the efficacy of lithium in the long-term treatment of bipolar disorder: should lithium (again) be recommended as the single preferred first-line treatment? Int J Bipolar Disord 2015; 3: 1.
23. Sidor MM, MacQueen GM. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. J Clin Psychiatry 2011; 72: 156-167.
24. Grunze H, Vieta E, Goodwin GM et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 2010; 11: 81-109.
25. Pacchiarotti I, Bond DJ, Baldessarini RJ et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry 2013; 170: 1249-1262.
26. Frye MA, Helleman G, McElroy SL et al. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry 2009; 166: 164-172.
27. Martin A, Young C, Leckman JF, Mukonoweshuro C, Rosenheck R, Leslie D. Age effects on antidepressant-induced manic conversion. Arch Pediatr Adolesc Med 2004; 158: 773-780.
28. Haeberle A, Greil W, Russmann S, Grohmann R. Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP. BMC Psychiatry 2012; 12: 153.
29. Grunze H, Vieta E, Goodwin GM et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry 2009; 10: 85-116.
30. Malhi GS. Have the CANMAT bipolar guidelines transmogrified from do matter to can matter? Bipolar Disord 2013; 15: 54-57.
31. Kessing LV, Hellmund G, Andersen PK. Predictors of excellent response to lithium: results from a nationwide register-based study. Int Clin Psychopharmacol 2011; 26: 323-328.